Patent US4316716A successfully refreshed from Google Patents.
Patent US1761167A successfully refreshed from Google Patents.
Patent US5051257A successfully refreshed from Google Patents.
US5051257A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antineoplastic solution and method for treating neoplasms
Assignee: Direct Therapeutics Inc
•
Filing: 1989-05-09
•
Granted: 1991-09-24
•
Expires: 2009-05-09
Abstract
Abstract Disclosed are antineoplastic solutions for direct intratumoral delivery. The solutions are formulated using antineoplastic agents dissolved in organic, water miscible, solvent vehicles. The vehicle is selected such that a) the agent is dissolved in the vehicle, b) the agent is stable and bioavailable in the vehicle, and c) the vehicle readily diffuses through and permeates tumorous tissue. The solution is injected directly into the tumor and, as the vehicle permeates the tumor tissue it transports the agent therewith. In this way therapeutically effective levels of antinoeplastic agent are effectively and rapidly delivered and disseminated into the tumor mass with little or no dissemination into surrounding healthy tissue.
Inventors
- 👤 Dennis D. Pietronigro
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 17:07
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K31/00; A61K31/16; A61K31/17; A61K9/00; A61K9/0012; A61K9/0019; A61P; A61P35/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
97 words
A method for treating neoplastic masses which comprises at least once injecting directly into a neoplastic mass a therapeutically effective volume of an antineoplastic solution consisting essentially of an organic, water miscible solvent vehicle selected from the group consisting of C1 through C4 alcohols having a partition coefficient of at least 0.1 and a chemotherapeutic antineoplastic agent solute, said solute being effectively stable and bioavailable in said solvent vehicle and being present in said solution at a concentration such that the resulting dose thereof in said neoplastic mass is at least two logs greater than the TD50.
Claim 2
Independent Claim
97 words
A method for treating neoplastic masses which comprises at least once injecting directly into a neoplastic mass a therapeutically effective volume of an antineoplastic solution consisting essentially of an organic, water miscible solvent vehicle selected from the group consisting of C1 through C4 alcohols having a partition coefficient of at least 0.1 and a chemotherapeutic antineoplastic agent solute, said solute being effectively stable and bioavailable in said solvent vehicle and being present in said solution at a concentration such that the resulting dose thereof in said neoplastic mass is at least two logs greater than the TD50.
Claim 3
Dependent Claim
97 words
An antineoplastic solution for the treatment of neoplastic masses by direct intratumoral delivery thereof, said solution consisting essentially of an organic, water miscible solvent vehicle selected from the group consisting of C1 through C4 alcohols having a partition coefficient of at least 0.1 and a chemotherapeutic antineoplastic agent solute, said solute being effectively stable and bioavailable in said solvent vehicle and being present in said solution at a concentration such that the resulting dose thereof in a neoplastic mass when delivered thereinto as one or more injections thereof is at least two logs greater than the TD50.
Claim 4
Dependent Claim
97 words
An antineoplastic solution for the treatment of neoplastic masses by direct intratumoral delivery thereof, said solution consisting essentially of an organic, water miscible solvent vehicle selected from the group consisting of C1 through C4 alcohols having a partition coefficient of at least 0.1 and a chemotherapeutic antineoplastic agent solute, said solute being effectively stable and bioavailable in said solvent vehicle and being present in said solution at a concentration such that the resulting dose thereof in a neoplastic mass when delivered thereinto as one or more injections thereof is at least two logs greater than the TD50.
Claim 5
Dependent Claim
12 words
The method of claim 1 wherein said antineoplastic agent is a nitrosourea.
Claim 6
Dependent Claim
10 words
The method of claim 3 wherein said nitrosourea is BCNU.
Claim 7
Dependent Claim
10 words
The method of claim 1 wherein said alcohol is ethanol.
Claim 8
Dependent Claim
11 words
The method of claim 4 wherein said ethanol is absolute alcohol.
Claim 9
Dependent Claim
28 words
The method of claim 1 wherein treatment of the neoplastic mass is undertaken as a plurality of injections of said antineoplastic solution into different regions of said mass.
Claim 10
Dependent Claim
14 words
The method of claim 1 wherein the neoplastic mass treated is a brain tumor.
Claim 11
Dependent Claim
37 words
The method of claim 8 wherein the neoplastic mass is a glioma and wherein the antineoplastic solution employed consists essentially of absolute alcohol as the organic, water misicible solvent vehicle and BCNU as the antineoplastic agent solute.
Claim 12
Dependent Claim
11 words
The antineoplastic solution of claim 2 wherein said alcohol is ethanol.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-23 | 1995-03-25 | 1995-09-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-23 | 1999-03-25 | 1999-09-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-23 | 2003-03-25 | 2003-09-24 | $7700.00 | Window Closed / Lapsed |